A software tool for organ-specific second cancer risk assessment from exposure to therapeutic doses.
Rep Pract Oncol Radiother
; 27(1): 170-175, 2022.
Article
em En
| MEDLINE
| ID: mdl-35402031
ABSTRACT
The aim of this study was the development of a software tool (SCRcalc) for the automatic estimation of the patient- and organ-specific cancer risk due to radiotherapy. SCRcalc was developed using the Python 3.8.7 programming language. It incorporates equations and parameters of mechanistic models for the calculation of the organ equivalent dose (OED), the excess absolute risk (EA R) and the lifetime attributable risk (LA R) of carcinogenesis for various organs due to radiotherapy. Data from differential dose-volume histograms, as defined by a treatment planning system, could be automatically inserted into the program. Eighteen different cancer risk estimates for various organs were performed of patients subjected to radiation therapy with conventional and modulated techniques. These software estimates were compared with manual calculations. SCRcalc was developed as a standalone executable program without any dependencies. It enables direct estimations of the OED and LAR for various organs at risk. An important aspect of the software is that it does not require pre-processing of the DVH data. No differences were found between the SCRcalc results and those derived from manual calculations. The newly developed software offers the possibility to medical physicists and radiation oncologists to directly estimate the probability of radiotherapy-induced secondary malignancies for various organs at risk.
Texto completo:
1
Bases de dados:
MEDLINE
Tipo de estudo:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Idioma:
En
Revista:
Rep Pract Oncol Radiother
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Grécia